Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
59.70
+0.70 (1.19%)
Dec 18, 2025, 2:31 PM CST
TPEX:4747 Market Cap
TPEX:4747 has a market cap or net worth of 2.68 billion as of December 19, 2025. Its market cap has decreased by -14.83% in one year.
Market Cap
2.68B
Enterprise Value
1.80B
Revenue
567.06M
Ranking
n/a
PE Ratio
35.54
Stock Price
59.70
Market Cap Chart
Since January 8, 2010, TPEX:4747's market cap has increased from 500.25M to 2.68B, an increase of 436.22%. That is a compound annual growth rate of 11.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 2.68B | -16.50% |
| Dec 31, 2024 | 3.21B | -12.10% |
| Dec 29, 2023 | 3.66B | 137.81% |
| Dec 30, 2022 | 1.54B | 46.08% |
| Dec 29, 2021 | 1.05B | -5.78% |
| Dec 31, 2020 | 1.12B | -4.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 238.84B |
| PharmaEssentia | 183.26B |
| Heron Neutron Medical | 82.78B |
| Lotus Pharmaceutical | 74.55B |
| Bora Pharmaceuticals Co., LTD. | 60.97B |
| Lin BioScience | 33.17B |
| Lumosa Therapeutics | 31.33B |
| Center Laboratories | 28.03B |